(Q46817511)

English

Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

0 references

type 2 diabetes

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

Markku Peltonen

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

Jaana Lindström

object named as

Jaana Lindström

3

0 references

Jaakko Tuomilehto

7

object named as

Jaakko Tuomilehto

1 reference

Europe PubMed Central

25 December 2017

Johan G. Eriksson

6

object named as

Johan Gunnar Eriksson

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

Timo E Saaristo

1

object named as

Timo Saaristo

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

author name string

Liisa Saarikoski

4

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

Jouko Sundvall

5

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

67-72

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

2

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Subclinical states of glucose intolerance and risk of death in the U.S.

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

The diabetes risk score: a practical tool to predict type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

A Danish diabetes risk score for targeted screening: the Inter99 study

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

The performance of a risk score in predicting undiagnosed hyperglycemia

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Performance of a predictive model to identify undiagnosed diabetes in a health care setting

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2005.011

21 January 2018

Identifiers

10.3132/DVDR.2005.011

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/16305061

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46817511&oldid=2133400556"